Use access key #2 to skip to page content.
$23.43 -0.13 (-0.55%)
11/21/2008 12:55 PM

Merck & Co., Inc. (MRK)

CAPS Rating:
****

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

View All Commentary (MRK)

Recs

1

Avatar jep2224 (< 20) Submitted: 3/24/08 12:15 PM : Outperform Start Price: $43.53 MRK Score: -2.67

A leading pharmaceutical growth company with multiple products in research or in the pipeline in human testing trial stage or near approval by FDA. Only one executive Ms. Wendy Yarno sold large shares of her position at $52 (52 week high $55),much higher than the present price of the stock,...smart don't you think so?. She will eventually receive additional stock option to make up for what she sold. The remaining executives sold between 1000 and 2000 shares, such a nominal amount. This is a major pharmaceutical research company in the world. The price is very cheap at this level. J. Paul Getty was once quoted saying, when asked how dd he made money in the stock market his answer was, if I can paraphrase, I buy when everyone is selling and I sell when everyone is buying.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links